Serkan İPEK

Tip 2 diyabetli hastalarda metabolik sendrom prevalansı

Amaç: Bu çalışma, tip 2 diyabetli hastalarda metabolik sendrom prevalansını değerlendirmek amacıyla yapılmıştır. Materyal ve Metod: Malatya Doğanşehir Devlet Hastanesi İç Hastalıkları Polikliniği’ne başvuran 112 tip 2 diyabetli hasta bel çevresi, arteryel kan basıncı, trigliserid ve HDL-kolesterol düzeyleri ölçülerek metabolik sendrom açısından değerlendirilmiştir. Bulgular: Çalışma grubu 29’u erkek (%25,9), 83’ü kadın (%74,1) olmak üzere toplam 112 tip 2 diyabetli hastadan oluşmaktadır. Metabolik sendrom prevalansı %80,4 olarak bulunmuştur. Bu oran erkeklerde %62,1, kadınlarda %86,7 olarak saptanmıştır. Tip 2 diyabetli kadınlarda metabolik sendrom prevalansı tip 2 diyabetli erkeklere göre anlamlı derecede daha yüksek bulunmuştur (p

Prevalence of metabolic syndrome in type 2 diabetic patients

Aim: This study was carried out to evaluate the prevalence of metabolic syndrome in type 2 diabetic patients. Material and method: A total 112 patients with type 2 diabetes who admitted to outpatient clinic of internal medicine in Malatya Doğanşehir Public Hospital were evaluated for metabolic syndrome by measuring of the waist circumference, arterial blood pressure, the level of triglycerides and HDL. Results: Patient group included total 112 type 2 diabetic patients, of these, 29 were male (25,9 %) and 83 were female (74,1 %). The prevalence of metabolic syndrome was 80,4 %. Male to female ratio was 62,1% / 86,7%. The prevalence of metabolic syndrome in type 2 diabetic female patients was found to be significantly higher than that of type 2 diabetic male patients (p

PDF

___

1. Gündoğdu AS. Metabolik sendrom, insülin direnci ve tip 2 diabetten korunma. Diabet Esasları. Birinci baskı 2006;12-21.
2. Sanders BH, Lubsch LM, West DS. Prevalence and treatment of metabolic syndrome in adolescents with type 2 diabetes. Ann Pharmacother 2006;40:1517- 21.
3. Tkac I. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis. Diabetes Research and Clinical Practice 2005;68:2-9.
4. Orna JAG, Arnal LML, Herguedas EM et al. Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. Rev Esp Cardiol 2004;57(6):507-13.
5. Alebiosu CO, Odusan BO. Metabolic syndrome in subject with type-2 diabetes mellitus. J Natl Med Assoc. 2004;96:817-21.
6. Foucan L, Deloumeaux J, Donnet JP et al. Metabolic syndrome components in Indian migrants with type 2 diabetes. Diabetes Metab 2006;32:337-42.
7. Najarian RM, Sullivan LM, Kannel WB et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risc factor for stroke. Arch Intern Med. 2006;166:106-11.
8. Csaszar A, Kekes E, Abel T et al. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Pressure. 2006;15:101-106.
9. Sanisoglu SY, Oktenli C, Hasimi A et al. Prevalence of metabolic syndromerelated disorders in large adult population in Turkey. BMC Public Health 2006, 6:92.
10. Onat A, Ceyhan K, Basar O et al. Metabolic syndrome major impact on coronary risk in a population with low cholesterol levels – A prospective and crosssectional evaluation. Atherosclerosis 2002. 165:285-92.
11. Metabolik Sendrom Araştırma Grubu. METSAR sonuçları. XX. Ulusal Kardiyoloji Kongresi. Antalya, 2004.
12. Hanley AJG, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome. Circulation. 2005;112:3713-21.
13. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. The Journal of Clinical Endocrinology and Metabolism. 2004;89:2601-7.
14. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
15. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-4.